Skip to main content

Displaying results 1 - 3 of 3
  • Content Type: Abstract

    Disease screening facilitates the reduction of disease prevalence in two ways: (1) by preventing transmission and (2) allowing for treatment of infected individuals. Hospitals choosing an optimal screening level must weigh the benefits of decreased… read more
    … diseases. Math Biosci. 2007;209:386�402. *Aaron Miller E-mail: aaron-miller@uiowa.edu (page number not for citation …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a significant source of morbidity and mortality. The majority of post-marketing surveillance for ADEs is passive. Information regarding ADEs is reported to the medical community in peer-reviewed journals. However, in… read more
    … Proc. ANLP97. Washington, DC; 1997: 16�9. *Chao Yang E-mail: chao-yang@uiowa.edu (page number not for citation …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a major cause of morbidity and mortality. However, post-marketing surveillance systems are passive and reporting is generally not mandated. Thus, many ADEs go unreported, and it is difficult to estimate and/or… read more
    … report-in full. JAMA. 2007;298:2185�7. *Jacob Simmering E-mail: jacob-simmering@uiowa.edu (page number not for …